Reprogenix Funding: $14M Raised, Series A (2025)

Reprogenix funding overview

Reprogenix is based in Hangzhou, China. Reprogenix has raised $14M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in November 2025. The round record for Reprogenix runs through 2025; nothing later has been disclosed. Investors on record include CRHC Fund, Yuanbio Venture Capital, Fu Zhe Capital, Sinowisdom, Orient Renaissance Capital, Lotus Lake Capital and 3 others. 9 distinct backers are named across the disclosed rounds.

Reprogenix at a glance

Total raised: $14M
Latest round: Series A
Latest round date: November 2025
Headquarters: Hangzhou, China
Notable investors: CRHC Fund, Yuanbio Venture Capital, Fu Zhe Capital, Sinowisdom, Orient Renaissance Capital, Lotus Lake Capital, Yuhang State-Owned Capital Investment, GAGE Capital

Frequently asked about Reprogenix funding

How much has Reprogenix raised?: Reprogenix has raised $14M in total disclosed funding across the rounds on record.
Who has invested in Reprogenix?: CRHC Fund, Yuanbio Venture Capital, Fu Zhe Capital, Sinowisdom, Orient Renaissance Capital, Lotus Lake Capital are named among the investors backing Reprogenix.
What was the latest Reprogenix funding round?: The most recent disclosed round is a Series A, announced in November 2025.
Where is Reprogenix based?: Reprogenix is based in Hangzhou, China.
When did Reprogenix last raise?: The last disclosed Reprogenix round closed in November 2025 at Series A.

Totals shown for Reprogenix aggregate every disclosed round on file. To see how that compares, browse the companies in Hangzhou and the investors behind them below.

Reprogenix Funding: $14M Raised, Series A (2025)

Reprogenix funding overview

Reprogenix at a glance

Frequently asked about Reprogenix funding

Companies related to Reprogenix (18)

Browse related funding lists (4)